May 16, 2011

Amylin Pharmaceuticals filed suit against Eli Lilly in federal court Monday concerning an agreement between the latter and German drug maker Boehringer Ingelheim to develop drugs for diabetes.

March 16, 2011

Amylin Pharmaceuticals and Takeda Pharmaceutical have suspended a mid-stage trial of an obesity drug over safety concerns, the two said Wednesday.

February 2, 2011

Eli Lilly’s and Amylin Pharmaceuticals’ Type 2 diabetes drug, Bydureon, appears to work better at promoting weight loss than drugs made by Takeda and Merck, but it could face a challenger of its own.

January 27, 2011

Amylin Pharmaceuticals continued to experience losses in sales and profits during fourth quarter 2010 and for the year as a whole, but losses were lower than in 2009, according to financial results released by the drug maker Wednesday.

December 20, 2010

Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.

December 9, 2010

Combining a diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals controls blood sugar and promotes weight loss more than insulin alone, according to a new study.

November 17, 2010

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 15, 2010

A leading charitable funder of and advocate for Type 1 diabetes research and a drug...

September 19, 2010

An investigational treatment made by French drug maker Sanofi-Aventis showed “significant” improvement in blood-glucose control...

June 20, 2010

Swiss drug maker Roche has started a risk-mitigation plan in the late-stage clinical trial of...

May 31, 2010

Amylin has named a new SVP research and development and SVP and chief medical officer,...

January 25, 2010

The Food and Drug Administration has approved a long-awaited treatment for Type 2 diabetes, the...